Elli Papaemmanuil, PhD, assistant professor in computational oncology, Memorial Sloan Kettering Cancer Center, spoke on current methods of classification and stratification for myelodysplastic ...

Authors acknowledge that both the 2022 World Health Organization and International Consensus Classification myelodysplastic syndrome criteria sets have value, while sorting out their similarities and ...

Incorporating Novel Targeted and Immunotherapeutic Agents in the Treatment of B-Cell Lymphomas Myelodysplastic syndrome (MDS) classification currently relies mainly on its morphologic features and ...

—Classifying myelodysplastic syndrome and secondary acute myeloid leukemia by genetic mutations rather than strictly by blast count may allow more patients to be eligible for AML and MDS clinical ...

MDS are a group of bone marrow (BM) failure disorders that share several key features. These include the presence of clonal hematopoiesis, inefficient differentiation resulting in cytopenias of the ...